These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6023750)

  • 1. [Qualitative demonstration of porphobilinogen in the urine in the framework of diagnosis of porphyria].
    Fillippini L; Siegenthaler W
    Dtsch Med Wochenschr; 1967 Apr; 92(15):718-9. PubMed ID: 6023750
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the excretion of 5-aminolevulinic acid and porphobilinogen in latent porphyria].
    KELENYI G; ARATO G; BUDA V; ORBAN S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1961; 78():205-13. PubMed ID: 14454906
    [No Abstract]   [Full Text] [Related]  

  • 3. [On determination of porphobilinogen in urine].
    Iarlykova EI; Lorie IuI; Krasiukova LI
    Lab Delo; 1966; 6():347-9. PubMed ID: 4175724
    [No Abstract]   [Full Text] [Related]  

  • 4. Porphyria induced in the rabbit by diethyl 1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate. I. Excretion of 5-aminolaevulic acid, porphobilinogen, coproporphyrin and protoporphyrin.
    HAEGER-ARONSEN B
    Acta Pharmacol Toxicol (Copenh); 1961; 18():165-9. PubMed ID: 13903511
    [No Abstract]   [Full Text] [Related]  

  • 5. Excretion of porphobilinogen and 5-aminolaevulinic acid in acute porphyria.
    ACKNER B; COOPER JE; GRAY CH; KELLY M; NICHOLSON DC
    Lancet; 1961 Jun; 1(7189):1256-60. PubMed ID: 13681256
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary dipyrrylmethenes in patients with porphyria. A preliminary study of the brown pigments in the urine of a case of acute intermittent porphyria.
    Sears WG; Eales L
    Enzyme; 1974; 17(1):11-6. PubMed ID: 4836422
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical differentiation of the porphyrias.
    Hindmarsh JT; Oliveras L; Greenway DC
    Clin Biochem; 1999 Nov; 32(8):609-19. PubMed ID: 10638943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary delta-aminolaevulic acid and porphobilinogen in different types of porphyria.
    HAEGER B
    Lancet; 1958 Sep; 2(7047):606-8. PubMed ID: 13588944
    [No Abstract]   [Full Text] [Related]  

  • 10. Best practice guidelines on first-line laboratory testing for porphyria.
    Woolf J; Marsden JT; Degg T; Whatley S; Reed P; Brazil N; Stewart MF; Badminton M
    Ann Clin Biochem; 2017 Mar; 54(2):188-198. PubMed ID: 27555665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of biochemically unclassifiable hepatic porphyria.
    Aguadé JP; Castells A; Indacochea A; Rodés J
    Br J Dermatol; 1969 Apr; 81(4):270-5. PubMed ID: 5778714
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one in the urine of patients with acute intermittent porphyria.
    Graham DJ; Brodie MJ; McColl KE; Moore MR; Goldberg A
    Eur J Clin Invest; 1979 Feb; 9(1):49-53. PubMed ID: 110600
    [No Abstract]   [Full Text] [Related]  

  • 13. The excretion of porphyrin-peptide conjugates in porphyria variegata.
    Rimington C; Lockwood WH; Belcher RV
    Clin Sci; 1968 Oct; 35(2):211-47. PubMed ID: 5721229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of acute porphyria].
    Mustajoki P; Kauppinen R
    Duodecim; 1986; 102(17):1218-21. PubMed ID: 3769820
    [No Abstract]   [Full Text] [Related]  

  • 15. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience].
    Zawirska B; Kwiatkowska W; Nowojska A
    Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004
    [No Abstract]   [Full Text] [Related]  

  • 16. [Porphyria and porphyrinuria].
    Schoenfeld N; Mamet R; Mevasser R; Atsmon A
    Harefuah; 1993 Dec; 125(12):449-52, 496. PubMed ID: 8112676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ether soluble porphyrins found in urine in acute porphyria and porphyria cutanea tarda.
    ERIKSEN L; ERIKSEN N; HAAVALDSEN S
    Scand J Clin Lab Invest; 1962; 14():6-10. PubMed ID: 13890580
    [No Abstract]   [Full Text] [Related]  

  • 18. AN EVALUATION OF A RECENT MODIFICATION OF THE WATSON-SCHWARTZ TEST FOR PORPHOBILINOGEN.
    TOWNSEND JD
    Ann Intern Med; 1964 Feb; 60():306-7. PubMed ID: 14114450
    [No Abstract]   [Full Text] [Related]  

  • 19. The porphyrinogenic effects of kryptopyrrole in the rat and the occurrence of urinary kryptopyrrole in human hereditary hepatic porphyria.
    Brodie MJ; Graham DJ; Thompson GG; Moore MR; Goldberg A
    Clin Sci Mol Med; 1976 May; 50(5):431-4. PubMed ID: 1277751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary excretion of porphyrins and their precursors. Longterm observations in acute intermittent porphyrias (author's transl)].
    Brugsch J; Müller H
    MMW Munch Med Wochenschr; 1979 Mar; 121(13):457-8. PubMed ID: 107424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.